ID: ALA5272414

Max Phase: Preclinical

Molecular Formula: C18H13FN2O

Molecular Weight: 292.31

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccc(F)cc1)c1ccc(-n2ccnc2)cc1

Standard InChI:  InChI=1S/C18H13FN2O/c19-16-6-1-14(2-7-16)3-10-18(22)15-4-8-17(9-5-15)21-12-11-20-13-21/h1-13H/b10-3+

Standard InChI Key:  RNMGCCPENKUPRK-XCVCLJGOSA-N

Associated Targets(Human)

Monoamine oxidase B 8835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 292.31Molecular Weight (Monoisotopic): 292.1012AlogP: 3.91#Rotatable Bonds: 4
Polar Surface Area: 34.89Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.05CX LogP: 3.80CX LogD: 3.78
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.54Np Likeness Score: -1.47

References

1. Guglielmi P, Mathew B, Secci D, Carradori S..  (2020)  Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors.,  205  [PMID:32920430] [10.1016/j.ejmech.2020.112650]

Source